Immunotherapy with anti-PSMA x anti-CD3 bispecific antibody stimulates potent killing of a human prostate cancer cell line and target mediated T cell activation in monkeys: A potential therapy for prostate cancer

被引：1
|
作者：
Chu, Seung Y.
Pong, Erik W. K.
Rashid, Rumana
Chen, Hsing
Chan, Emily W.
Phung, Sheryl
Endo, Nancy A.
Ardila, Maria C.
Bonzon, Christine
Leung, Irene W. L.
Muchhal, Umesh S.
Moore, Gregory L.
Bernett, Matthew J.
Desjarlais, John R.
Szymkowski, David E.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-5000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5000
引用
收藏
页数：4
相关论文
共 50 条
  • [41] T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct
    Bernd Schlereth
    Cornelia Quadt
    Torsten Dreier
    Peter Kufer
    Grit Lorenczewski
    Nadja Prang
    Christian Brandl
    Sandra Lippold
    Kathy Cobb
    Kathleen Brasky
    Eugen Leo
    Ralf Bargou
    Krishna Murthy
    Patrick A. Baeuerle
    Cancer Immunology, Immunotherapy, 2006, 55 : 503 - 514
  • [42] T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct
    Schlereth, B
    Quadt, C
    Dreier, T
    Kufer, P
    Lorenczewski, G
    Prang, N
    Brandl, C
    Lippold, S
    Cobb, K
    Brasky, K
    Leo, E
    Bargou, R
    Murthy, K
    Baeuerle, PA
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (05) : 503 - 514
  • [43] Target-dependent T-cell Activation by Coligation With a PSMA x CD3 Diabody Induces Lysis of Prostate Cancer Cells
    Buehler, Patrick
    Molnar, Eszter
    Dopfer, Elaine P.
    Wolf, Philipp
    Gierschner, Dorothee
    Wetterauer, Ulrich
    Schamel, Wolfgang W. A.
    Elsaesser-Beile, Ursula
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (06) : 565 - 573
  • [44] Combination of AMG 160, a PSMA x CD3 half-life extended bispecific T-cell engager (HLE BiTE) immune therapy, with an anti-PD-1 antibody in prostate cancer (PCa)
    Paweletz, Katherine L.
    Li, Shyun
    Bailis, Julie M.
    Juan, Gloria
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [45] Retronectin and anti-CD3 monoclonal antibody actived T cell combined anti-PD1 therapy in heavy-treated renal cell cancer
    Zhao, Ling-Di
    Li, Tiepeng
    Li, Wei
    Yang, Yonghao
    Gao, Quanli
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Radiolabeled anti-PSMA antibody J591 immunotherapy is associated with favorable circulating tumor cell (CTC) count control in men with castration-resistant prostate cancer
    Date, Pravin
    Karir, Beerinder S.
    Batra, Jaspreet S.
    Jhanwar, Yuliya
    Beltran, Himisha
    Nanus, David M.
    Bander, Neil H.
    Tagawa, Scott T.
    CANCER RESEARCH, 2015, 75
  • [47] Bispecific anti-CD3xanti-CD155 antibody mediates T-cell immunotherapy in human haematologic malignancies
    Ma, Li
    Ma, Juan
    Sun, Xin
    Liu, Honggang
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (03) : 522 - 531
  • [48] ADOPTIVE IMMUNOTHERAPY OF CANCER USING CELL-POPULATIONS STIMULATED WITH ANTI-CD3 ANTIBODY AND IL2
    ANDERSON, PM
    BACH, FH
    LEONARD, AS
    OCHOA, AC
    FASEB JOURNAL, 1988, 2 (04): : A688 - A688
  • [49] REGULATION BY ANTI-CD2 MONOCLONAL-ANTIBODY OF THE ACTIVATION OF A HUMAN T-CELL CLONE INDUCED BY ANTI-CD3 OR ANTI-T CELL-RECEPTOR ANTIBODIES
    YSSEL, H
    AUBRY, JP
    MALEFIJT, RD
    DEVRIES, JE
    SPITS, H
    JOURNAL OF IMMUNOLOGY, 1987, 139 (09): : 2850 - 2855
  • [50] Affinity tuned Xmab®2+1 anti-mesothelin x anti-CD3 bispecific antibody induces selective T cell-dependent cellular cytotoxicity of human ovarian cancer cells
    Zeng, Veronica G.
    Faber, Matthew S.
    Bernett, Matthew J.
    Avery, Kendra N.
    Zeytounian, John L.
    Rashid, Rumana
    Muchhal, Umesh S.
    Moore, Gregory L.
    Desjarlais, John R.
    Hedvat, Michael
    CANCER RESEARCH, 2020, 80 (16)
12345